Shares of Alembic Pharmaceuticals rose 5% in early trading on March 31 after receiving final approval from the US Food and Drug Administration (USFDA) for...
Shares of Lupin rose 2% intraday on March 27 after the drugmaker received preliminary approval from the US Food and Drug Administration (USFDA) for Valbenazine...
Shares of Zydus Lifesciences were trading in the early hours of March 22, after the company’s subsidiary received USFDA approval for tofacitinib tablets. Zydus Pharmaceuticals...
On March 21, Pharma major Lupin shares increased 1.6% in the early trade after the company’s alliance partner Caplin Steriles got two final approvals from...
Lupin shares rose in early trading on March 14 after receiving a “no observation” certificate from the US Food and Drug Administration (USFDA). At 9:16...
Yondelis is the brand name for an injection called Trabectedin, which has been used for antitumor chemotherapy medication to treat soft tissue sarcoma and ovarian...
Glenmark Pharmaceuticals said Monday that its US unit had received preliminary approval from US health regulators for a generic calcipotriene and betamethasone dipropionate foam to...
Alembic Pharmaceuticals said Wednesday that its wholly-owned subsidiary, Aleor Dermaceuticals, has received final approval from US health regulators for its generic Docosanol cream to treat...